Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Pacific Biosciences of California Company Profile (NASDAQ:PACB)

Consensus Ratings for Pacific Biosciences of California (NASDAQ:PACB) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.00 (69.49% upside)

Analysts' Ratings History for Pacific Biosciences of California (NASDAQ:PACB)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/26/2013Maxim GroupBoost Price TargetBuy$4.00 -> $8.00ViewTweet This Rating  Share This Rating on StockTwits
1/14/2013Maxim GroupBoost Price TargetBuy$3.00 -> $4.00ViewTweet This Rating  Share This Rating on StockTwits
10/26/2012Maxim GroupUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
7/30/2012Morgan StanleyDowngradeEqual Weight -> Underweight$1.50ViewTweet This Rating  Share This Rating on StockTwits
7/27/2012Piper JaffrayDowngradeNeutral -> UnderweightViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/23/2012 forward)